RNASE3 and neuropathy: In the case of the treatment of neuropathy patients [63], a significant reduction in total cholesterol, triglycerides, LDL-cholesterol, serum C-reactive protein (sCRP), tumor necrosis factor-α (TNF-α), eosinophilic cationic protein (ECP), fibrinogen and the chemokine RANTES (Regulated And Normal T cell Expressed and Secreted) could be achieved.